Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children

  • Yoon, Jisun (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Oh, Seak Hee (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Kim, Hyun Jin (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Park, Sang Hyoung (Department of Pediatrics, Asan Medical Center Children's Hospital) ;
  • Ye, Byong Duk (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Yang, Suk-Kyun (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Kyung Mo (Department of Pediatrics, Asan Medical Center Children's Hospital)
  • Received : 2015.09.08
  • Accepted : 2015.11.14
  • Published : 2015.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Primary sclerosing cholangitis (PSC) is a rare condition that can be associated with inflammatory bowel disease (IBD). The aim of this study was to evaluate PSC and its association with IBD in children. Methods: We retrospectively enrolled 13 pediatric patients (<18 years) with PSC treated at Asan Medical Center between June 1989 and December 2013. Clinical findings and long-term outcomes were investigated. During the same period, the incidence of PSC among IBD patients was evaluated among 600 Crohn disease (CD) and 210 ulcerative colitis (UC) patients. Results: All 13 study patients diagnosed with PSC also presented with IBD. Eleven boys and two girls with a median age of 15.0 years old (9.0-17.8 years) were included. The cumulative incidence of PSC for UC was 5.7% (12 of 210) and 0.2% for CD (1 of 600), respectively. PSC occurred during follow-up for IBD for five patients (38.5%) whereas, IBD developed during follow-up for PSC for two patients (15.4%), and was diagnosed during the initial work-up for PSC for 6 patients (46.2%). For the 77.3 month median follow-up period, 9/13 patients (69.2%), neither the clinical symptoms nor blood test results worsened. Two cases (15.4%) developed liver cirrhosis and underwent liver transplantation. Among 13 PSC patients with IBD, two (15.4%) developed colorectal cancer, and no one developed cholangiocarcinoma. Conclusion: All patients with PSC in this study had associated IBD. The incidence of PSC was not rare compared to reports in adults. PSC should be considered during the management of IBD and vice versa in children.

Keywords

References

  1. Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology. ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol 2015;110:646-59; quiz 660. https://doi.org/10.1038/ajg.2015.112
  2. Vergani D, Mieli-Vergani G. Autoimmune hepatitis and PSC connection. Clin Liver Dis 2008;12:187-202, x. https://doi.org/10.1016/j.cld.2007.11.012
  3. Schrumpf E, Boberg KM, Karlsen TH. Primary sclerosing cholangitis - the Norwegian experience. Scand J Gastroenterol 2015;50:781-96.
  4. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003;38:210-7.
  5. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology 2013;58:1392-400. https://doi.org/10.1002/hep.26454
  6. Lindström L, Lapidus A, Ost A, Bergquist A. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Dis Colon Rectum 2011;54:1392-7. https://doi.org/10.1097/DCR.0b013e31822bbcc1
  7. Broome U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006;26:31-41. https://doi.org/10.1055/s-2006-933561
  8. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997;41:522-5. https://doi.org/10.1136/gut.41.4.522
  9. Sano H, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, et al. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2011;18:154-61. https://doi.org/10.1007/s00534-010-0319-8
  10. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population- based analysis. Am J Gastroenterol 2007;102:1042-9. https://doi.org/10.1111/j.1572-0241.2007.01103.x
  11. Faubion WA Jr, Loftus EV, Sandborn WJ, Freese DK, Perrault J. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr 2001;33:296-300. https://doi.org/10.1097/00005176-200109000-00013
  12. Jung JA, Kwak IK, Lee HR, Jang SH, Kim KM, Yoo ES. A case of overlap syndrome with auoimmune hepatitis and cholangiopathy in a child. Korean J Pediatr Gastroenterol Nutr 2006;9:269-75.
  13. Kim JS, Choe YH, Kim CJ, Kim WS, Kim IO, Seo JK. A case of primary sclerosing cholangitis with ulcerative colitis. J Korean Pediatr Soc 1996;39:1448-54.
  14. Hong J, Song MK, Ko JS, Kang GH, Kim WS, Seo JK. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome in a 10-year-old girl with ulcerative colitis. Korean J Pediatr 2009;52:504-7. https://doi.org/10.3345/kjp.2009.52.4.504
  15. Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009;7:239-45. https://doi.org/10.1016/j.cgh.2008.10.019
  16. MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983;149:39-44. https://doi.org/10.1148/radiology.149.1.6412283
  17. Bjornsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002;51:731-5. https://doi.org/10.1136/gut.51.5.731
  18. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
  19. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002;56:48-54. https://doi.org/10.1067/mge.2002.125367
  20. McDiarmid SV, Anand R; SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report. Clin Transpl 2003:119-30.
  21. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995;22:1404-8.
  22. Khaderi SA, Sussman NL. Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep 2015;17:17. https://doi.org/10.1007/s11894-015-0438-0
  23. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, et al; AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:738-45. https://doi.org/10.1053/j.gastro.2009.12.037

Cited by

  1. The IBD and PSC Phenotypes of PSC-IBD vol.20, pp.4, 2018, https://doi.org/10.1007/s11894-018-0620-2
  2. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center vol.67, pp.1, 2018, https://doi.org/10.1097/mpg.0000000000001927
  3. Long‐term outcomes of pediatric‐onset primary sclerosing cholangitis: A single‐center experience in Japan vol.49, pp.12, 2019, https://doi.org/10.1111/hepr.13421
  4. Geoepidemiologic variation in outcomes of primary sclerosing cholangitis vol.12, pp.4, 2015, https://doi.org/10.4254/wjh.v12.i4.116
  5. Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease: Early Diagnosis and Management Affect Clinical Outcome vol.238, pp.None, 2015, https://doi.org/10.1016/j.jpeds.2021.07.047